Original Investigation
Editorial Comment
Beta-Blockers in the Critically Ill: Friend or Foe?

https://doi.org/10.1016/j.jacc.2021.07.006Get rights and content
Under an Elsevier user license
open archive

Key Words

acute care
ARDS
COVID
metoprolol

Cited by (0)

Christie Ballantyne, MD, served as the Guest Editor for this paper.

The author attests they are in compliance with human studies committees and animal welfare regulations of the author’s institution and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.

Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.